Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Not so new. The Life Science Report article was originally posted here August 4. The $8.50 price target in that article was from Marcel Wijma's Van Leeuwenhoeck Research report on RVX from May 11. The most recent valuation was from the July 29 Zacks that had a price target of $5.
